CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02299700
NCT02299700N/ACompleted
CompareCT.gov

A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder

Janssen Research & Development, LLC·observational·Posted Nov 24, 2014·Updated Oct 23, 2017

In Brief

An observational study evaluating No Intervention for Autism Spectrum Disorder. Completed, enrolled 34 participants across 3 sites.

Detailed Summary

The purpose of this study is to assess the usability of the Janssen Autism Knowledge Engine (JAKE) as a system to monitor clinical outcomes in autism spectrum disorder (ASD) (severe abnormalities in the development of many basic psychological functions that are not normal for any stage in development. These abnormalities are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 24, 2014
Enrollment StartSep 30, 2014
Primary CompletionApr 24, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.6 years ago

Interventions

No Interventionother

The usability of the Janssen Autism Knowledge Engine (JAKE) as a system to monitor clinical outcomes in Autism Spectrum Disorder (ASD) will be observed.